Mosaic Shares Retreat as Challenging H2 2025 Overshadows 2026 Recovery Outlook and Brazil Asset Review

The Mosaic Company (NYSE: MOS) reported a difficult conclusion to fiscal 2025, as management cited significant demand erosion in the U.S. market and margin pressure from volatile input costs. Despite a 5.3% share price drop following the earnings call, the fertilizer giant is pivoting toward a 2026 recovery strategy centered on the normalization of phosphate production, the rapid scaling of its Biosciences division, and the potential divestment of non-core Brazilian assets.

Mosaic’s fourth-quarter performance was defined by a bifurcated landscape: operational recovery in phosphates set against a backdrop of "tough economics" for domestic growers. CEO Bruce Bodine characterized the second half of 2025 as exceptionally challenging, noting that U.S. demand dropped significantly as farmers grappled with uncertainty regarding government payments. In the Phosphate segment, Q4 production reached 1.7 million tonnes with an EBITDA margin of $108 per tonne. However, investors focused on the "stripping margin erosion" cited by analysts, driven by elevated sulfur prices that have compressed margins despite steady nutrient pricing. Looking ahead to 2026, management expects a 50% year-over-year increase in phosphate production, largely driven by the increased availability of the Faustina facility. This operational ramp-up is critical to offsetting the headwinds experienced in 2025. Meanwhile, Mosaic Biosciences emerged as a high-growth bright spot; the division doubled its net sales to $68 million in 2025 and is projected to double again in 2026. To support these growth initiatives and maintain balance sheet flexibility, the company has set 2026 capital expenditures at approximately $1.5 billion. Strategic portfolio optimization is also moving to the forefront. CFO Luciano Pires addressed the complexities of the Brazilian market, explaining that inventory valuation mechanics in the region—where nutrients are purchased rather than mined—prevent rising prices from translating into immediate EBITDA gains. Consequently, Mosaic is pursuing "strategic alternatives" for selected Brazilian assets. The company is also seeking to unlock value from non-traditional sources, including the monetization of Florida land holdings and the extraction of critical minerals like niobium from its existing co-product streams. Market reaction remained bearish in the immediate aftermath of the call, with MOS shares falling 5.3% to $26.98. The stock currently sits 28.9% below its 52-week high, reflecting investor skepticism over the timing of a demand rebound. While the 2026 outlook promises efficiency gains and a leaner asset base, the near-term focus for institutional investors remains on the company's ability to manage input cost volatility and successfully execute its asset divestiture program in South America.